Jason Haddock has over two decades of financial, commercial and operational leadership experience in the biopharmaceutical industry.
Mr Haddock has held a variety of leadership roles at biopharma companies where he oversaw finance, commercial and business development strategies in the US and worldwide.
He was chief financial officer of Array Biopharma and was instrumental in developing a research, development and commercialisation strategy that culminated in the successful launch and commercialisation of two oncology
therapies and Array’s acquisition by Pfizer for $11.4 billion. Prior to Array Biopharma, he worked at Bristol-Myers Squibb in a variety of finance, strategic, commercial and business development capabilities including as chief financial officer and chief operating officer for business units in Asia Pacific, Europe and the US.
Mr Haddock holds a Bachelor of Science in Accounting from Illinois State University, and an Executive MBA from Washington University in St Louis - Olin Business School.
